Follow-up of GSTM1, GSTT1, and NAT2 genotyped patients with knee or hip replacement
EXCLI Journal · 18.06.2025 · 24 · 677-689
DOI: 10.17179/excli2025-8565 ↗Kurz gefasst
Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 18.06.2025. Verfasst von Selahattin Bozkurt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Catholic Clinics in the Märkischer Kreis, location St. Vincenz Krankenhaus, Menden, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A total of 147 patients, genotyped for glutathione S-transferases M1 (GSTM1) and T1 (GSTT1) and for N-acetyltransferase 2 (NAT2), who had undergone total joint replacement of the knee or hip joint between August 2004 and June 2007, showed with 45% a remarkably lower portion of the GSTM1-negative genotype compared to both a local control (51%), an external control (52%) and the portion reported in the literature for the European population (50%). In contrast, the portions of GSTT1-positive (84%) and slow NAT2 (55.1%) patients of the initial collective were unremarkable, compared to both controls. To elucidate a possible impact of this interesting finding on the long-term outcome, the patients were contacted in December 2015. Afterwards, they were interviewed using a self-prepared questionnaire. The average follow-up time was 9 years. At the time of follow-up, 57 patients were deceased, 46 patients did not respond and 12 patients declined the interview. A total of 32 patients participated in the follow-up. The mean age of the followed-up patients was 75.9±8.3 years, whereas the mean age of all patients at the time of surgery was 70.9±9 years. The portions of the GSTM1-negative genotype (15 out of 32; 47%), the GSTT1-positive genotype (24 out of 32; 75%) and the slow NAT2 status (17 out of 32; 53%) in the followed-up patients were comparable to those of the initial collective. The follow-up results of the patients after 9 years were unable to clarify the significance of the observed lower portion of GSTM1-negative patients. In view of a recently published omics study reporting a reduced GSTM1 activity in tissue attached on hip implants explanted due to aseptic loosening, the striking portion of the GSTM1-negative genotype in this present study may encourage further investigation into the impact of this gene in patients with hip or knee replacement.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Catholic Clinics in the Märkischer Kreis, location St. Vincenz Krankenhaus, Menden, Germany.
- Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany.
- Catholic Clinics in the Märkischer Kreis, location St. Elisabeth Hospital, Iserlohn, Germany.
Zitieren
APA
Bozkurt, S., Selinski, S., Blaszkewicz, M., Reinders, J., Hengstler, J. G., Niggemann, L., & Golka, K. (2025). Follow-up of GSTM1, GSTT1, and NAT2 genotyped patients with knee or hip replacement. EXCLI Journal, 24, 677-689. https://doi.org/10.17179/excli2025-8565
Vancouver
Bozkurt S, Selinski S, Blaszkewicz M, Reinders J, Hengstler JG, Niggemann L, et al. Follow-up of GSTM1, GSTT1, and NAT2 genotyped patients with knee or hip replacement. EXCLI Journal. 2025;24:677-689. doi:10.17179/excli2025-8565
BibTeX
@article{Bozkurt2025,
author = {Bozkurt, Selahattin and Selinski, Silvia and Blaszkewicz, Meinolf and Reinders, Jörg and Hengstler, Jan G and Niggemann, Lukas and Golka, Klaus},
title = {Follow-up of GSTM1, GSTT1, and NAT2 genotyped patients with knee or hip replacement},
journal = {EXCLI Journal},
year = {2025},
volume = {24},
pages = {677--689},
doi = {10.17179/excli2025-8565}
}
EUVIMED